Cardinal Capital Management Inc (North Carolina)’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.8M Sell
38,484
-103
-0.3% -$27.1K 1.3% 21
2026
Q1
$10.3M Buy
38,587
+186
+0.5% +$50.4K 1.33% 22
2025
Q4
$9.63M Buy
38,401
+389
+1% +$103K 1.28% 24
2025
Q3
$10.9M Buy
38,012
+174
+0.5% +$46.6K 1.51% 19
2025
Q2
$9.93M Buy
37,838
+1,149
+3% +$280K 1.46% 20
2025
Q1
$8.54M Buy
36,689
+664
+2% +$161K 1.32% 22
2024
Q4
$8.26M Buy
36,025
+1,731
+5% +$397K 1.3% 23
2024
Q3
$7.66M Buy
34,294
+414
+1% +$91K 1.19% 28
2024
Q2
$6.89M Buy
33,880
+328
+1% +$66.7K 1.16% 29
2024
Q1
$7.33M Buy
33,552
+2,969
+10% +$654K 1.19% 30
2023
Q4
$6.95M Buy
30,583
+100
+0.3% +$21K 1.32% 25
2023
Q3
$6.13M Sell
30,483
-4,251
-12% -$897K 1.25% 28
2023
Q2
$7.2M Buy
34,734
+455
+1% +$88.3K 1.45% 21
2023
Q1
$6.76M Buy
34,279
+91
+0.3% +$18.7K 1.4% 24
2022
Q4
$6.92M Sell
34,188
-169
-0.5% -$33K 1.47% 20
2022
Q3
$6.04M Buy
34,357
+446
+1% +$91.3K 1.43% 19
2022
Q2
$6.83M Buy
33,911
+361
+1% +$77K 1.56% 15
2022
Q1
$7.6M Buy
33,550
+537
+2% +$126K 1.54% 16
2021
Q4
$8.91M Sell
33,013
-252
-0.8% -$62.4K 1.76% 11
2021
Q3
$8.04M Sell
33,265
-790
-2% -$199K 1.74% 14
2021
Q2
$8.07M Buy
34,055
+5
+0% +$1.14K 1.7% 15
2021
Q1
$7.46M Sell
34,050
-146
-0.4% -$29.3K 1.65% 15
2020
Q4
$5.98M Buy
34,196
+255
+0.8% +$44K 1.42% 23
2020
Q3
$5.49M Buy
33,941
+114
+0.3% +$18.1K 1.51% 21
2020
Q2
$4.83M Buy
33,827
+12
+0% +$1.66K 1.39% 26
2020
Q1
$3.67M Sell
33,815
-651
-2% -$93.8K 1.21% 33
2019
Q4
$5.01M Sell
34,466
-410
-1% -$59.2K 1.3% 31
2019
Q3
$5.03M Sell
34,876
-25
-0.1% -$3.65K 1.39% 27
2019
Q2
$5.18M Sell
34,901
-171
-0.5% -$23.9K 1.47% 24
2019
Q1
$4.61M Buy
35,072
+223
+0.6% +$27.5K 1.32% 29
2018
Q4
$3.78M Buy
34,849
+377
+1% +$50.5K 1.25% 32
2018
Q3
$5.14M Sell
34,472
-79
-0.2% -$12K 1.46% 22
2018
Q2
$5.33M Sell
34,551
-222
-0.6% -$33.5K 1.61% 16
2018
Q1
$4.83M Sell
34,773
-1,161
-3% -$171K 1.52% 18
2017
Q4
$4.92M Buy
35,934
+172
+0.5% +$22.7K 1.49% 19
2017
Q3
$4.64M Sell
35,762
-566
-2% -$75.5K 1.46% 19
2017
Q2
$4.81M Buy
36,328
+1,476
+4% +$181K 1.59% 17
2017
Q1
$4.3M Sell
34,852
-265
-0.8% -$31.4K 1.55% 21
2016
Q4
$3.87M Buy
35,117
+100
+0.3% +$11.1K 1.47% 27
2016
Q3
$4.14M Buy
35,017
+727
+2% +$85.7K 1.62% 19
2016
Q2
$3.84M Sell
34,290
-155
-0.4% -$16.7K 1.56% 22
2016
Q1
$3.47M Buy
34,445
+589
+2% +$56.5K 1.46% 28
2015
Q4
$3.6M Sell
33,856
-657
-2% -$67.8K 1.61% 24
2015
Q3
$3.22M Buy
34,513
+38
+0.1% +$3.93K 1.5% 28
2015
Q2
$3.59M Buy
34,475
+942
+3% +$98.1K 1.57% 23
2015
Q1
$3.63M Sell
33,533
-22
-0.1% -$2.26K 1.53% 22
2014
Q4
$3.11M Buy
33,555
+92
+0.3% +$8.13K 1.42% 37
2014
Q3
$2.92M Buy
33,463
+538
+2% +$48.6K 1.39% 38
2014
Q2
$2.9M Buy
32,925
+976
+3% +$84.5K 1.44% 37
2014
Q1
$2.7M Sell
31,949
-1,493
-4% -$119K 1.39% 37
2013
Q4
$2.63M Buy
33,442
+152
+0.5% +$13K 1.35% 40
2013
Q3
$2.83M Buy
33,290
+456
+1% +$38.4K 1.61% 33
2013
Q2
$2.82M Buy
+32,834
New +$2.73M 1.67% 28

Other funds holding LH

Cardinal Capital Management Inc (North Carolina)'s LH Position: Q2 2026 in Review

Cardinal Capital Management Inc (North Carolina) reduced its Labcorp (LH) stake by 0.27% in Q2 2026, selling an estimated $27.1K and leaving 38,484 shares worth $10.8M. The position accounts for 1.3% of the portfolio, ranked #21.

Cardinal Capital Management Inc (North Carolina) first reported a position in LH in Q2 2013 and has held it in 53 quarters since. The position peaked at $10.9M in Q3 2025. 500 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Cardinal Capital Management Inc (North Carolina) held 38,484 shares of Labcorp worth $10.8M as of Q2 2026.
  • Cardinal Capital Management Inc (North Carolina) sold 103 Labcorp shares in Q2 2026, an estimated $27.1K.
  • Labcorp made up 1.3% of Cardinal Capital Management Inc (North Carolina)'s portfolio in Q2 2026, its #21 holding.
  • Cardinal Capital Management Inc (North Carolina) first reported a position in Labcorp in Q2 2013 and has held it in 53 quarters since.
  • Cardinal Capital Management Inc (North Carolina)'s Labcorp position peaked at $10.9M in Q3 2025.
  • 500 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q2 2026, filed 21 Jul 2026.